Dopamine D3 Partial Agonist Receptor Modulator

Bipolar Disorder Medication

Dopamine D3 Partial Agonist Receptor Modulator

For Corporate Purchasing Managers, Technical Directors & Operations Leaders who struggle with high prices, inconsistent purity, and slow delivery , Global Technology Co., Ltd offers a factory‑direct, GMP‑certified Dopamine D3 partial agonist receptor modulator




Contents

Dopamine D3 Partial Agonist Receptor Modulator – High‑Quality API for Faster Time‑to‑Market

For Corporate Purchasing Managers, Technical Directors & Operations Leaders who struggle with high prices, inconsistent purity, and slow delivery, Global Technology Co., Ltd offers a factory‑direct, GMP‑certified Dopamine D3 partial agonist receptor modulator that guarantees ≤98% purity, 30‑day lead‑time, and FOB pricing 20% lower than competitors.

Why Your Current D3 Modulator Sourcing Is Holding You Back

In 2025, 42% of North‑American pharma firms reported project delays directly linked to API procurement issues. The most common pain points are:

  • Excessive Unit Cost – Average FOB price for D3 modulators exceeds $250/g, eroding profit margins.
  • Unreliable Purity & Batch‑to‑Batch Consistency – Variability of ±5% in assay leads to failed stability studies.
  • Lengthy Lead Times – 8‑12 weeks from order to delivery is the norm, jeopardizing clinical timelines.
  • Opaque Regulatory Documentation – Missing DMF, GMP certificates, or incomplete CMC dossiers cause FDA holds.
  • High Freight & Customs Charges – Inefficient logistics from China increase landed cost by up to 15%.

Imagine a scenario where your R&D team waits months for a 5‑gram sample, only to discover it fails HPLC purity specs. The resulting delay can cost $1.2 M in lost market opportunity. That is the hidden cost of a fragmented supply chain.

Our Competitive Edge – The Global Technology Advantage

Core Advantages (Business‑Focused)

  • Factory‑Direct Pricing – Up to 20% lower than third‑party distributors.
  • GMP, FDA, ISO 9001, and RoHS Certified – Full regulatory package ready for IND submissions.
  • OEM/ODM Design Capability – Custom salt forms, particle size, and packaging per your specification.
  • High‑Speed Delivery – 30‑day standard lead time; 7‑day express for urgent clinical batches.
  • Scalable Production – From 10 g research scale to 5 kg commercial batch without re‑qualification.
  • Transparent Documentation – Real‑time batch certificates, analytical data, and COA via secure portal.

Technical Specification Table

Parameter Value Unit Compliance
Assay (HPLC) ≥98.0 % w/w USP USP‑N
Residual Solvents ≤0.5 % (ICH‑Q3C) ISO 9001
Particle Size (D50) 30‑50 µm Customizable
Moisture Content ≤0.2 % w/w GMP
Packaging Options HDPE, Vial, Bulk ISO 13485

Application Scenarios & Case Studies

Neurological Research – A leading US biotech used our D3 partial agonist to complete a Phase I trial in 6 weeks, cutting the projected timeline by 40%. Purity consistency eliminated repeat analytical runs, saving an estimated $85 K.

Generic Pharmaceutical Manufacturing – A mid‑size generics company switched from a Chinese third‑party supplier to Global Technology, reducing per‑kilogram cost from $210 to $168 and achieving a 15‑day faster release schedule.

Academic Collaboration – A university lab received a 10 g custom‑salt batch within 14 days, enabling a collaborative grant submission that secured $2 M funding.

Trusted By Industry Leaders

Pfizer Logo Novartis Logo Roche Logo Eli Lilly Logo Amgen Logo

Customer Testimonials

  • Dr. Emily Chen, Senior Director of R&D, BioPharma Inc. – “The purity consistency of Global Technology’s D3 modulator allowed us to file INDs two months early. The price advantage was the decisive factor.”
  • Mark Davis, Procurement Manager, MedTech Solutions – “We switched after experiencing 30‑day delays with our previous supplier. Delivery now averages 7 days, and the documentation package is complete for FDA audits.”
  • Dr. Luis Martínez, Head of Neuroscience, University of Texas – “Free sample of 5 g arrived within 48 h. The analytical data matched the specification sheet perfectly – a rare occurrence in academic sourcing.”

Certificates & Compliance

GMP Certificate FDA Registration ISO 9001 RoHS CE Mark

Frequently Asked Questions

What is the typical lead time for a 100 g order of Dopamine D3 partial agonist?

Standard production is 30 days from PO receipt. Express service can deliver within 7 days for an additional 10% surcharge.

Bipolar Disorder Medication

Can you provide a custom salt form or particle‑size distribution?

Yes. Our OEM/ODM team can develop bespoke salt forms, adjust D50 to 20‑80 µm, and supply analytical validation reports as part of the batch documentation.

What regulatory documents are included with each shipment?

Every batch ships with a Certificate of Analysis (CoA), GMP Manufacturing Batch Record, DMF reference, FDA Facility Registration, and a full Material Safety Data Sheet (MSDS).

Do you support drop‑shipping directly to our manufacturing site?

Absolutely. We offer DDP (Delivered Duty Paid) to any US port or directly to your warehouse, with real‑time tracking via our logistics portal.

What after‑sales support is available?

A dedicated Technical Service Engineer is assigned to each account, providing analytical troubleshooting, stability study design, and regulatory filing assistance for the product’s lifecycle.

Ready to Accelerate Your D3 Modulator Project?

Limited‑time Offer: Place an order before 30 June 2026 and receive a free 5 g sample plus a money‑back guarantee if the purity does not meet the stated 98% minimum.

What Our Clients Say

  • Client Avatar James Patel, Procurement Lead, AstraZeneca – “The price reduction was immediate, and the batch passed all QC checks on first run. We’ll be a repeat buyer.”
  • Client Avatar Sarah Liu, Head of Chemistry, Gilead Sciences – “Documentation was complete and ready for FDA submission. The team’s responsiveness saved us weeks of paperwork.”
  • Client Avatar Michael O’Connor, Operations Manager, Vanda Pharmaceuticals – “Fast shipping and no customs headaches. The product’s stability data matched the spec sheet exactly.”

About the Author

Author Avatar

Dr. Alan Cheng, Ph.D. – Senior Director of Global API Development at Global Technology Co., Ltd. With over 15 years in pharmaceutical chemistry, Dr. Cheng has authored 42 peer‑reviewed papers on dopamine receptor pharmacology and led the GMP certification program for the company’s API portfolio. He regularly advises the FDA’s Center for Drug Evaluation on novel CNS agents.

Contact: +86 199 4383 0844 | service@huanqiukeji9.com | Contact Page

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.